Stay updated about latest news and where to meet us!
Samplix is pleased to announce we will be demonstrating our recently launched Xdrop™ system at the EMBL Heidelberg Cancer Genomics 2019 conference in Heidelberg.
To see more and register for the event, please visit the conference website:
Samplix is pleased to announce we will be demonstrating our recently launched Xdrop™ system at the Oxford Global 11th Annual NGS & Clinical Diagnostics Congress in London.
Samplix is pleased to announce we will be attending the Genomic Medicine 2019 Nordic conference 13 - 14 November at Kennedy Center at Rigshospitalet in Copenhagen.
Samplix is pleased to announce we will be attending the Genomic Medicine 2019 Cambridge conference 20 - 21 November at Murray Edwards College in Cambridge, UK
02 September 2019. Today, Samplix is happy to announce the commercial launch of our Xdrop™ instrument for the targeted enrichment of long genomic regions from as little as 1 ng of DNA.
Scientists in the genomics field can now routinely capture up to 100 kb long genomic regions, based upon very limited target sequence information (100-200 bp of sequence). Using Xdrop™ technology together with long- or short-read sequencers makes it possible to sequence into regions that were previously inaccessible.
The types of genomic regions that are now unlocked by the Xdrop™ technology include:
Today, Samplix announced the commercial launch of its Xdrop™ sample preparation products for PCR-free target enrichment yet maintaining PCR-level specificity.
To read more, please see the full press release here:
January 2019. Samplix is pleased to announce that the company has been selected by the European Commission among the winners of the prestigious Horizon 2020 – SME Instrument program, obtaining €1.9 million to mature its proprietary Xdrop™ technology. The selection process was highly competitive with more than 1.800 applicants and a success rate of only about 3%.
Samplix’ proprietary Xdrop™ technology comprises novel microfluidics, chemistry and bioinformatics in a simple work process that allows scientists and clinicians to partition millions of single molecules in droplets, thereby enabling both targeted enrichment and high-quality amplification of single molecules for sequencing analysis.
The Xdrop™ technology is currently in beta test at leading research institutions world-wide.
“We are excited to receive recognition and support by the European Commission for completion of our product development towards commercial launch of the Xdrop™ solution later this year” said CEO Lars Kongsbak.
To read more about Horizon 2020 SME awards, please viisit European Commission website:
ContactMileparken 282730 HerlevDenmark
firstname.lastname@example.orgPhone: (+45) 82 30 45 00
CVR 32 30 93 21
Connect with us
2019 Samplix ApS. All rights reserved. For Research Use Only. Not for use in diagnostic procedures.